Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein

BRONX, N.Y., April 3, 2020 /PRNewswire-HISPANIC PR WIRE/ — Montefiore Health System and <span…

BRONX, N.Y., April 3, 2020 /PRNewswire-HISPANIC PR WIRE/ — Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial. This treatment has the potential to help people who have serious lung complications as a result of COVID-19. Recruitment for the trial began in March and is still underway. 

Montefiore

Montefiore-Einstein is one of 46 testing sites nationwide and is the first site in New York State to open. NIAID launched the multi-center international effort to determine if remdesivir, a broad-spectrum antiviral drug, acts against COVID-19 viral infection. Remdesivir has shown promise in animal models of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), both caused by human coronaviruses.

The randomized, double-blind, placebo-controlled trial is being led by principal investigator Barry Zingman, M.D., professor of medicine at Einstein and clinical director, infectious diseases, in the Moses division of Montefiore Health System. The trial is «adaptive,» meaning it can be modified to include other investigational treatments. «This flexibility allows us to add additional therapies to the trial step-by-step to improve treatment as the pandemic continues,» said Dr. Zingman.

Trial participants are hospitalized patients with a laboratory-confirmed coronavirus infection and lung complications, including rattling sounds when breathing, a need for supplemental oxygen, abnormal chest X-rays showing pneumonia, or the need for a mechanical ventilator.

People in the treatment group will receive 200 mg of remdesivir intravenously on the first day of their enrollment in the study and will receive another 100 mg each day for the duration of hospitalization, for up to 10 days total. The placebo group will receive an equal volume of a solution that resembles remdesivir but contains inactive ingredients.

Montefiore and Einstein’s robust clinical trial infrastructure contributed to its selection and rapid approval for participation.

No therapies have yet been approved by the U.S. Food and Drug Administration for treating COVID-19.

Remdesivir, an investigational antiviral therapy, was developed by Gilead Sciences, Inc.

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 11 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D. students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

 

SOURCE Montefiore Health System; Albert Einstein College of Medicine

Purchasers of Charmin Freshmates Flushable Wipes: A Class Action Settlement May Affect Your Rights

PHILADELPHIA, April 3, 2020 /PRNewswire-HISPANIC PR WIRE/ — The following statement is being issued by HF Media LLC regarding the Charmin Freshmates Class Action Settlement.

WHO IS AFFECTED?

A class action settlement has been reached involving Charmin Freshmates Flushable Wipes. The settlement involves all pre-moistened wipes sold under the Charmin brand name bearing the word «flushable» on the package label («Wipes»). The lawsuit claims that the Wipes are not actually flushable….

PHILADELPHIA, April 3, 2020 /PRNewswire-HISPANIC PR WIRE/ — The following statement is being issued by HF Media LLC regarding the Charmin Freshmates Class Action Settlement.

WHO IS AFFECTED?

A class action settlement has been reached involving Charmin Freshmates Flushable Wipes. The settlement involves all pre-moistened wipes sold under the Charmin brand name bearing the word «flushable» on the package label («Wipes»). The lawsuit claims that the Wipes are not actually flushable. P&G denies these allegations and maintains that the Wipes perform as advertised. You may be an eligible class member if you purchased the Wipes in the State of New York, between May 23, 2011 and March 6, 2020.

WHAT DOES THE SETTLEMENT PROVIDE?

In connection with this settlement, The Procter & Gamble Company («P&G») will change the labeling of the Wipes and agreed to stricter industry-standard testing protocols. P&G will also pay a partial cash refund of (i) seventy cents ($0.70) per package purchased, up to $6.30 per Household without proof of purchase; or (ii) one dollar and twenty cents ($1.20) for the first package with proof of purchase (and $1.00 for any additional packages with proof of purchase), up to $50.20 per Household with proof of purchase. Proof of purchase means the actual label or bar code portion of the package of the Product (not a photocopy or digital image), or the original or photocopy or digital image of an itemized sales receipt originally generated by a retail seller showing the date and place of purchase, name of the product purchased, and the amount paid.

WHAT ARE MY OPTIONS?

You must submit a claim online by September 21, 2020 or by mail so that it is received (not merely postmarked) no later than September 21, 2020 to receive a payment. The deadline may be extended, please check the website for updates.

You can opt out of the class and keep your right to sue P&G on the released claims by June 25, 2020. The settlement will release all claims related to Plaintiff’s contentions that P&G’s marketing, advertising, and sale of the Wipes with the representations «flushable,» «septic safe,» and «safe for sewer and septic systems» were false or misleading. There is no release of claims for personal injury or property damage allegedly caused by use of the Wipes.

You can also object to the settlement by June 25, 2020, which does not affect your ability to file a claim. For details on how to opt out, object, or to file a claim, please visit www.BelfioreWipeSettlement.com or contact the Claim Administrator.

If you do nothing you will not receive a payment and you will be bound by the decisions of the Court.

COURT HEARING AND ATTORNEYS’ FEES

The Court will hold a hearing on July 23, 2020 at 11:00 a.m. ET to consider whether to approve the settlement. If the settlement is approved, the attorneys for the class will ask the Court for an award from P&G of up to $3,200,000 in fees, costs, and expenses, and a class representative payment of $10,000 for the named plaintiff. Note that the hearing date may change without further notice to you although any such change will be reflected on the website. You may attend the hearing, but you do not have to. Plaintiff’s Motion for Attorneys’ Fees and Costs will be posted on the settlement website after it is filed.

MORE INFORMATION

This is only a Summary. For more information, please visit: www.BelfioreWipeSettlement.com or contact the Claim Administrator by calling 1 (833) 930-2423 or writing to Belfiore v. P&G, PO Box 34880, Philadelphia, PA, 19101-4880. You may also contact Plaintiff’s counsel, Wolf Popper LLP, 845 Third Avenue, New York NY 10022. The case name is Belfiore v. Procter & Gamble Company, U.S District Court for the Eastern District of York Case No. 2:14-cv-04090.

SOURCE HF Media LLC

Emmy Award Winner and 3 time Grammy Nominee B.Slade presents Bethany Rose, World Premiere «Love of My Life» video/single

LOS ANGELES, April 3, 2020 /PRNewswire-PRWeb/ — Emmy Award Winner and 3 time Grammy nominee B.Slade presents Bethany Rose in the world premiere of the «Love of My Life» video/single. Bethany Rose is a Los Angeles-based singer/songwriter and multi-instrumentalist. Bethany has shared the stage with such artists such as Mary J. Blige, Lupe Fiasco,…

LOS ANGELES, April 3, 2020 /PRNewswire-PRWeb/ — Emmy Award Winner and 3 time Grammy nominee B.Slade presents Bethany Rose in the world premiere of the «Love of My Life» video/single. Bethany Rose is a Los Angeles-based singer/songwriter and multi-instrumentalist. Bethany has shared the stage with such artists such as Mary J. Blige, Lupe Fiasco, Yolanda Adams, Jordan Smith, Dionne Warwick, Amber Riley, and Kristin Chenoweth, just to name a few. Over the past two years, she has toured as a vocalist with legendary Argentinian composer and singer, Leo Dan. She has also contributed vocals to a variety of studio recordings such as Childish Gambino’s «Awaken My Love,» and to such television shows as «Glee» and «Army Wives».

The world premiere of the newly released video/single entitled «Love of My Life,» featuring B. Slade, carries a universal theme of love and an uplifting tone. At the heart of the song, it is about finding true love and commitment, leaving hurt in the past, and looking forward to the future and what it holds. The song depicts a love story from beginning to end; two people desiring true love and finding it in the most unexpected way. What began as a solo song for Bethany Rose, eventually turned into a masterful duet written and sung by both Bethany Rose and B.Slade. «Love of My Life» entails the life of the two singers going back and forth, expressing their love for each other and in the end ultimately sharing wedding vows. This is truly a song that inspires those seeking love, those that are in love, and those that are married that have already found love. It has the ability to touch the hearts of all demographics, races, and ages.

Two-time Emmy award winner and three-time Grammy nominated artist B.Slade ranks as a top favorite among A-listers and is often called upon to write, produce, and perform alongside musical idols ranging from Janet Jackson to Snoop Dogg. B.Slade began his journey over 20 years ago and has since written and produced over 300 songs. B.Slade makes memorable appearances in all genres of music.

For more information, radio servicing and interview inquiries regarding Bethany Rose, contact Judy Groover at 202-361-3939 or jgroover@rockmediaconcepts.com.

About Bethany
Bethany has shared the stage with artists such as, Mary J. Blige, Lupe Fiasco, Yolanda Adams, Jordan Smith, Dionne Warwick, Amber Riley, and Kristin Chenoweth, just to name a few. Over the past two years, she has toured as a vocalist with legendary Argentinian composer and singer, Leo Dan. She has also contributed vocals to a variety of studio recordings such as Childish Gambino’s «Awaken My Love,» and to such television shows as «Glee» and «Army Wives».

Because of her love of tropical music and always thinking outside the box, in 2018, she teamed up with Los Angeles based producer Ivan Castro to create an English/Spanish salsa version of her original pop/R&B song, «Goodbye». The song was released in December 2018 for worldwide distribution. At the end of 2019, she teamed up with Montreal based producer Ricky Campanelli, and writer David Lopera to create several original R&B infused bachata songs as a follow up to «Goodbye». These songs are set for release in 2020. Most recently she has teamed up with artist/producer, B.Slade to produce her much-awaited debut EP album. Bethany Rose and B.Slade co-wrote the songs on the album. She will be releasing the first single off of the album called «Love of My Life,» featuring B. Slade in April 2020. (http://www.bethanyrosemusic.com)

About BSLADE
As a highly sought-after songwriter and producer, B.Slade has written and produced for some of the biggest artists in the industry including Chaka Khan («I Love Myself»), Sheila E. («Fiesta»), Faith Evans («Paradise»), and Angie Fisher, for which he wrote and co-produced her 2014 smash hit single, «I.R.S.» – – garnering Ms. Fisher’s first Grammy nomination and B.Slade’s third. He also co-wrote several songs on Elijah Blake’s Def Jam debut LP, including the smash hit «I Just Wanna…» (whose video reached over 14 million views on YouTube) and its title track «Shadows & Diamonds», and has been featured prominently in background vocal arrangements on several songs. B.Slade also co-wrote and co-produced actress & singer Tisha Campbell-Martin’s single, «Steel Here», which has received over 2.3 million video plays on YouTube. He is credited for closely working on the entirety of Ms. Campbell-Martin’s upcoming album release. B.Slade was instrumental in creating legendary singer Chaka Khan’s 2017 single from her own imprint, iKahn Sounds. «I Love Myself» (written and produced by B.Slade) was the lead single introducing the world to Chaka’s own label and was featured on the final season of Netflix’s hit show «The Get Down». More recently, B.Slade was featured as a guest vocalist and songwriter/producer of various songs on Snoop Dogg’s «Bible of Love» gospel album, and its lead single «Words Are Few,» which was both written and produced by B.Slade. http://www.bsladenow.com

 

SOURCE B.Slade

Through COVID-19 Pandemic, Seaboard Marine Carries Your Critical Commodities

MIAMI, April 3, 2020 /PRNewswire-HISPANIC PR WIRE/ — For nearly 40 years, Seaboard Marine has served the Western Hemisphere carrying cargo to some of the world’s hardest-hit countries in the aftermath of natural disasters. But, no situation has come close to the recent pandemic affecting nearly every country on earth….

MIAMI, April 3, 2020 /PRNewswire-HISPANIC PR WIRE/ — For nearly 40 years, Seaboard Marine has served the Western Hemisphere carrying cargo to some of the world’s hardest-hit countries in the aftermath of natural disasters. But, no situation has come close to the recent pandemic affecting nearly every country on earth. This extraordinary epidemic has tested the limits of our business continuity protocols. The urgency of this situation has also strengthened our partnerships with federal and local governments as well as our most loyal customers who import and export critical commodities that help fight the spread of the novel coronavirus COVID-19.

PortMiami has three cargo terminals with Seaboard Marine exclusively operating an 87-acre facility. The Seaboard Marine facility at PortMiami has remained fully operational and open, pictured here unloading critical commodities during the COVID-19 situation.

Since the spread of the virus, Seaboard Marine has been working with various seaport and government officials, both within the U.S. and abroad, to ensure we can continue to operate as an essential service while making necessary adjustments to ensure the expeditious transport of cargo and supplies. Many of our customers throughout the United States and Latin America contribute tremendously to meeting the need for critical products such as medical supplies, pharmaceuticals, and food.

One of those customers is DeRoyal, a manufacturer of medical supplies, with facilities throughout the U.S., as well as manufacturing plants in Costa Rica, Dominican Republic, and Guatemala. Elizabeth Reed, Sr. Director of Quality and Regulatory at DeRoyal, said, «Seaboard Marine is a critical transportation service supplier of raw materials to DeRoyal for manufacturing of medical products. These medical products are sold directly to hospitals, trauma centers, group purchasing organizations, and physician offices. DeRoyal depends on Seaboard Marine to continuously transport containers with material to enable us to actively sustain our global supply of finished medical products.»

Governments throughout Latin America and the Caribbean, like their counterparts in the U.S. and elsewhere in the world, have recently placed varying limits on mobility and certain types of work. Most, though, have recognized the importance of international trade, particularly essential commodities. Nonetheless, it has been challenging, at times, to meet the transportation needs of our customer’s factories. But all of the offices within the Seaboard network including those overseas are ensuring that cargo containers, trucks, and needed local paperwork are provided, so the urgently manufactured masks and gowns are promptly delivered via Seaboard Marine ships for quick transit.

In addition to threatening lives, this pandemic has interrupted the normal order of society. However, not all dissimilar to a natural disaster, business continuity is in our blood, and we are always prepared in advance. With over 90% of our office-based staff now working remotely while also keeping our cargo terminals and vessels operating at a high standard, we work with our customers to use our combined assets and infrastructure to urgently fight against the spread of the virus, case in point SanMar.

Seattle-based SanMar is an award-winning supplier of apparel and accessories to 22 retail, private label, and mill brands. John Janson, Global Logistics Director at SanMar, said, «As the nation’s largest supplier of wholesale apparel, SanMar has been moved by the impact of this pandemic. We’re now working in a consortium, with other large apparel manufacturers, to quickly produce five hundred million medical masks for the U.S. healthcare industry. Leveraging our factories in Haiti and Honduras, we rely on Seaboard Marine’s dedicated service to PortMiami to transport these critical medical items throughout the United States

Juan Kuryla, Director at PortMiami, said, «Seaboard Marine, a long-time incredible partner, is noted for their efficiency and schedule integrity. We know that vessels carrying these critical medical supplies made in nearby factories in Central America, Haiti, and the Dominican Republic must promptly discharge for these cargoes to quickly reach doctors and hospitals in the U.S. The entire PortMiami family including the U.S. Coast Guard, Customs and Border Protection, longshoremen and our security team are proudly committed to helping make it happen.»

Media Contact:
Chris Concepcion
chris.concepcion@seaboardmarine.com

Photo – https://mma.prnewswire.com/media/1141119/Seaboard_Marine_Vessels_at_Berth_at_PortMiami.jpg 

SOURCE Seaboard Marine Ltd. Inc.

March of Dimes Encourages People to Step Up! to Support Moms and Babies during the COVID-19 Pandemic

ARLINGTON, Virginia, April 2, 2020 /PRNewswire-HISPANIC PR WIRE/ — March of Dimes today launched a new virtual campaign, called Step Up!, to…

ARLINGTON, Virginia, April 2, 2020 /PRNewswire-HISPANIC PR WIRE/ — March of Dimes today launched a new virtual campaign, called Step Up!, to raise vital support for moms and babies during the COVID-19 pandemic causing the ongoing global health crisis. The new virtual fundraiser will replace this year’s March of Dimes’ annual in-person March for Babies events that for the past 50 years have seen thousands of people march as a way to fundraise. Due to social distancing and stay-in-place orders, March of Dimes is encouraging supporters across the country to Step Up! by taking part in a virtual walk – safely at home or wherever they can – in order to support moms and babies during their greatest time of need. 

March of Dimes Foundation Logo

«It is imperative that moms and babies have access to the care and resources required for a healthy start each and every day, and the need has become even more critical in our current environment,» said Stacey D. Stewart, President and Chief Executive Officer of March of Dimes. «During this unprecedented time, March for Babies Step Up! is so vitally important because through the incredible fundraising efforts of our supporters, we can continue to help moms and babies as well as learn more about this novel disease. We are so thankful our supporters are able to virtually participate in this innovative fundraising activity that will make a difference in the lives of families everywhere.»

Beginning today, March for Babies is asking participants to register to virtually march at marchforbabies.org. The virtual March for Babies will commence across the country with participants tracking their steps using smart phones or fitness watches and collecting donations for their steps. Every step will be tracked and totaled through the Charity Miles mobile app, culminating in a virtual celebration on May 15. Participants will also have the opportunity to engage in a series of fun, virtual challenges throughout the campaign to boost their step count, share personal stories about why they’re «stepping up» and ultimately raise awareness of the critical needs of mothers and babies right now.

«Expecting mothers can’t pause pregnancy. The COVID-19 pandemic is putting a strain on the healthcare system, and at this time, the health risks to moms and babies remain mostly unknown, however they are the ones who depend on the health system for support from pregnancy through delivery,» shared Dr. Rahul Gupta, Senior Vice President and Chief Medical and Health Officer at March of Dimes. «There is an urgent need, due to the COVID-19 pandemic, to support families with a baby in the Neonatal Intensive Care Unit (NICU) and ensure that moms-to-be have the latest health information to protect themselves and their infants.»

Even in the best of times, moms and babies rely on March of Dimes programs, research, advocacy and health information. There are families right now imagining preparing to labor or new parents concerned for their baby in the NICU, and that is why March for Babies will proceed, but in a new way.

«I believe the March of Dimes mission to support and protect moms and babies has never been more urgent than it is today and I’m honored to have been able to help kick off the Step Up! campaign through a virtual launch event last week,» shared Eli Manning, retired New York Giants Quarterback and New York City March for Babies Vice Chairman.  «March of Dimes is an organization built on the idea that when we come together, we can achieve great things. And, honestly this year’s March for Babies seemed unlikely, but we worked to develop a game plan, and the simple answer is – we will all ‘step up’ to help raise critical funds needed during this unprecedented time.»

For more than 80 years, March of Dimes has pioneered research, led programs, provided educational resources and enabled policy change so that every mom and baby can have the best possible start. The funds raised through Step Up! will continue to support research for COVID-19 treatments that are safe for pregnant and lactating moms, fundraising and advocacy efforts needed to help those families directly impacted by COVID-19, resources and training for doctors and nurses in the ICU and NICU, and the development of educational materials for moms-to-be and families about what they should know to protect themselves.

For more information on how to sign up to Step Up! and fundraise, please visit www.marchforbabies.org. To download the Charity Miles app, click here from your mobile device to download the Charity Miles App. Step along with us on Facebook, Instagram and Twitter, and share your journey using #MarchforBabies and #MFBStepUp!

About March of Dimes
March of Dimes leads the fight for the health of all moms and babies. We support research, lead programs and provide education and advocacy so that every baby can have the best possible start. Building on a successful 80-year legacy of impact and innovation, we empower every mom and every family. Visit marchofdimes.org or nacersano.org for more information. Visit shareyourstory.org for comfort and support. Find us on Facebook and follow us on Instagram and Twitter.

Logo – https://mma.prnewswire.com/media/513643/March_of_Dimes_Foundation_Logo.jpg

Logo – https://mma.prnewswire.com/media/1140945/MFBStepUp_Logo.jpg

SOURCE March of Dimes

Tablo® Hemodialysis System Receives FDA Clearance for Home Dialysis

SAN JOSE, Calif., April 2, 2020 /PRNewswire-HISPANIC PR WIRE/ — Outset Medical, a leading med tech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced the Food and Drug Administration (FDA) cleared the Tablo Hemodialysis System for patient use in the home. The new home clearance expands Tablo’s existing labeled indication for use in acute and chronic care facilities, which for the first time enables healthcare providers the same dialysis machine…

SAN JOSE, Calif., April 2, 2020 /PRNewswire-HISPANIC PR WIRE/ — Outset Medical, a leading med tech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced the Food and Drug Administration (FDA) cleared the Tablo Hemodialysis System for patient use in the home. The new home clearance expands Tablo’s existing labeled indication for use in acute and chronic care facilities, which for the first time enables healthcare providers the same dialysis machine from the ICU to the home. 

Tablo enters the market at a critical time in the midst of the COVID-19 pandemic and renewed national focus on home dialysis for improving patient outcomes while lowering cost.  In mid-2019, President Trump and United States Department of Health and Human Services Secretary Alex Azar announced an Executive Order to help Americans with kidney failure.  A major component of the policy was ensuring 80% of all new dialysis patients start therapy at home or get transplanted by 2025.  The emergence of COVID-19 further heightens the urgency for giving current in-center dialysis patients the option to treat at home.

«Tablo was designed to simplify dialysis, making it easier and more accessible for patients to take advantage of the safety, convenience and flexibility of dialyzing at home,» said Outset Medical Chief Executive Officer, Leslie Trigg.  «We are proud to offer them this new, life-enhancing option, particularly in light of the COVID-19 related challenges dialysis patients and providers are experiencing.»

Currently, more than 500,000 Americans undergo dialysis treatments three or more times each week, typically lasting four hours per treatment.  Approximately 100,000 new patients start treatment annually.  Yet only 12% receive it at home where they’re more comfortable, productive and empowered. 

POSITIVE TRIAL RESULTS

A prospective, multicenter, home hemodialysis trial with 30 patients was completed in 2019 and confirmed the Tablo system is safe and effective for home use.  The results were published in November 2019 in Hemodialysis International.

Troy Plumb, M.D., the principal study investigator and the Division Chief of Nephrology and Associate Professor of Medicine at the University of Nebraska Medical Center College of Medicine in Omaha, said, «My patients, colleagues and I are excited for Tablo to be available for home use.  The trial made it clear the system is easy to learn and performs well in the home environment.  I believe that Tablo will open up opportunities for patients to pursue home hemodialysis and take more control over their lives and care.»

One of those patients is 62-year-old Texas resident and technology consultant Richard Crawford.  He has had a kidney transplant that lasted 17 years and is currently on a transplant list.  Over the years, he has had thousands of dialysis treatments at various centers as well as on home hemodialysis.  He found using Tablo at home to be very intuitive, allowing him to dialyze while remaining productive during treatment.

«The home part of the Tablo trial only lasted eight weeks, but was eye opening,» he said. «The system is extremely easy to set up and use, so I wasn’t wasting hours on dialysis-related tasks.  I was able to work at my desk during treatments, which was wonderful for my productivity.  The system provided me with a new level of independence due to the ease of setup and maintenance.  «When the trial ended and they had to pick up the Tablo, I tried talking them out of it.  I really hated seeing it go.»

Outset will begin a controlled rollout for home use at select sites over the coming months to ensure the highest level of training and support for Tablo home patients. This program will be balanced with the need to supply health systems, hospitals, and clinics with devices to support a surge of demand for dialysis treatments driven by COVID-19.  More information about availability for patients and providers can be found at www.outsetmedical.com.

Tablo was designed in Silicon Valley to reduce the cost and complexity of dialysis care. Requiring only an electrical outlet and tap water to operate, the mobile Tablo system frees patients and providers from expensive clinic infrastructure.  The machine’s functionality enables it to serve as a dialysis clinic on wheels. Wireless data, sensor-based automation and an animated touchscreen make the system easy to learn and use.  Leading health systems and medical centers across the U.S. use Tablo for hospital and clinic dialysis, and the U.S. Department of Health and Human Services (HHS) awarded a contract for the use of Tablo in communities hit by natural disasters.

Award Winning Technology

Last April, Outset was a winner of the KidneyX Redesign Dialysis Competition, a partnership between the U.S. Department of Health and Human Services and the American Society of Nephrology to support innovative strategies for tackling kidney disease. Outset’s winning concept marries data from Tablo’s unique sensors and automation systems with physiologic data from the patient with an eye toward creating personalized dialysis treatments that improve patient outcomes.

Outset’s Tablo System was also recently recognized with a Gold Edison Award in the medical patient experience category. The Edison Awards honor game-changing innovations at the forefront of new product and service development, marketing and human-centered design. Nominees were judged by a panel of more than 3,000 leading business executives including past award winners, academics and leaders in the fields of product development, design, engineering, science and medicine. Tablo received the top prize in its category, the Gold Award. 

ABOUT OUTSET MEDICAL

Silicon Valley-based Outset Medical is dedicated to technology-driven service model innovation aimed at reducing cost and transforming the patient care experience. Outset’s Tablo System is FDA-cleared for use in acute, chronic care and home settings.  For more information visit www.outsetmedical.com and follow the company on Twitter at @OutsetMedical.

GENERAL CONTACT

www.outsetmedical.com

SOURCE Outset Medical, Inc.

Host of Miss New York USA Vows to Bring Heroic NY HealthCare Workers on 5 Star Vacation Featured on Global Child «Travel with Purpose» show on Amazon Prime Video.

NEW YORK, April 2, 2020 /PRNewswire-HISPANIC PR WIRE/ — Augusto Valverde creator of the world travel show Global Child «Travel with Purpose» and host of Miss New York USA 2020 vows to bring several heroic NYC healthcare workers on an all-expenses paid vacation to an exotic destination in…

NEW YORK, April 2, 2020 /PRNewswire-HISPANIC PR WIRE/ — Augusto Valverde creator of the world travel show Global Child «Travel with Purpose» and host of Miss New York USA 2020 vows to bring several heroic NYC healthcare workers on an all-expenses paid vacation to an exotic destination in 2021.

«People need hope and our healthcare workers across the country are truly acting heroically. I can’t help everyone, but I can give back by bringing a couple of them on one of our next shoots and offering them the rest and reward they deserve,» says Valverde.

After his sister delivered a healthy baby boy on March 29th at Mt Sinai Hospital in Manhattan amid the covid-19 pandemic, Valverde says he has a debt of gratitude to the healthcare workers of New York.

«It will be my pleasure to bring a couple more of our medical heroes and give back to them whenever, however I can. Maybe we’ll get them to skydive or scuba dive with sharks like we did… after facing the coronavirus they’ll be able to face anything!»

Valverde a former theology student, who saw his Season 3 filming interrupted, also has words of encouragement for other struggling professionals.  «Right now, as the mood worldwide darkens in the face of this pandemic; we need to remember that we are each called to be the light of the world. This virus is invisible, and I believe that in order to overcome it, in addition to social distancing we need to access invisible tools like love, hope, faith, peace, patience and kindness. We are all spiritual beings and part of one Global family. You are a Global Child because no matter what you believe, who you vote for, your race or gender, we have so much more in common than what sets us apart. It’s time to set aside our differences, think of the safety of others first, love one another as a Global family and pray. We need to rise up in faith instead of succumbing to fear. I know we’ll get past this storm together… already it’s helping us to rediscover what truly matters.»

Global Child will resume filming Season 3 as soon as the travel bans are lifted. 

About Global Child
Augusto Valverde has filmed the luxury adventure world travel show Global Child in 23 countries as they share positive life lessons and give back to the communities they visit.

Global Child has been featured on major airlines like American Airlines, Iberia and are currently streaming Season One on Amazon Prime with a reach of almost one billion viewers.  Valverde, a volunteer Christian jail chaplain based in Los Angeles, also hosted this year’s Miss New York USA beauty pageant.  He is currently writing a book for Simon Schuster about life lessons.  You can see Season 1 of Global Child on Amazon Prime Video and connect with Augusto via Instagram @GlobalChildTV and find out more on: www.GlobalChildTV.com

Contact:
www.GlobalChildTV.com 
IG @GlobalChildTV
Press Inquiries: +13057992557
augusto@globalchildtv.com

Photo – https://mma.prnewswire.com/media/1140744/Global_Child_Children_Photo.jpg
Logo –  https://mma.prnewswire.com/media/1140743/Global_Child_Logo.jpg

SOURCE Global Child

American Honda Reports March Auto Sales in the Face of Difficult Market Conditions

TORRANCE, California, April 1, 2020 /PRNewswire-HISPANIC PR WIRE/ —

<table cellspacing="0"…

TORRANCE, California, April 1, 2020 /PRNewswire-HISPANIC PR WIRE/ —

American Honda

Honda

Acura

Total

Cars

Trucks

Total

Cars

Trucks

Total

Cars

Trucks

Q1

298,785

131,845

166,940

270,253

123,407

146,846

28,532

8,438

20,094

-19.2%

-22%

-16.8%

-18.9%

-22.1%

-16.1%

-21.6%

-20.6%

-22%

Total

Cars

Trucks

Total

Cars

Trucks

Total

Cars

Trucks

March

77,153

37,175

39,978

70,116

34,953

35,163

7,037

2,222

4,815

-48%

-47.2%

-48.8%

-47.7%

-46.9%

-48.5%

-51.2%

-51.6%

-51%

«As a society, we’re all in this together. After a strong start to the year, industry sales are going to suffer in the short term, and we have suspended auto production as part of our effort to carefully manage our business in the face of the steep decline in demand,» said Steven Center, vice president of Automobile Sales at American Honda. «At Honda, we are focused more than ever on supporting our customers, our dealers, our associates, and the communities where we live and work in the presence of this unprecedented threat to our health and the economy. Our country is going to come back strong and we are going to come back strong, and we know there are better times ahead.»

Honda Acura

BRAND REPORTS

Sales

COVID-19 Initiatives & Customer Support

With sales up 0.2% after the first two months of 2020, and both brands off to a strong start in the first 10 days of March, the COVID-19 crisis quickly took its toll on March and 1st quarter sales results.

  • Considering the severe market impact, most Honda and Acura products continued to perform well in March.
  • However, combined with declining demand from cautious consumers, hundreds of Honda and Acura dealers were closed in the 2nd half of March in compliance with mandates imposed on businesses by state and local governments.
  • Honda and Acura dealers that were able to remain open did so, focusing their efforts on taking care of existing customers through vehicle service, maintenance, and repair, while preserving the health and safety of their employees.

 

  • Honda is initiating a comprehensive new effort to harness the spirit of community in responding to the challenge of the COVID-19 pandemic.
  • This includes a $1 million pledge to address the immediate needs of communities across the U.S., Canada and Mexico in providing the most vulnerable with access to food.
  • Other initiatives include the donation of Personal Protective Equipment and use of 3D printers in Honda operations to produce protective face shields for healthcare providers and other actions to help people combat the COVID-19 pandemic. For more information, click here.
  • As the COVID-19 pandemic can add financial stress to the lives of our customers, Honda and Acura have offered to help customers who have financed their vehicle through Honda Financial Services or Acura Financial Services with payment extensions and deferrals, as well as available late fee waivers.
  • Honda is also providing an industry-first special offer for first responders and medical professionals, out of respect for their contribution to our communities across the country

 

 

American Honda Vehicle Sales for March 2020

Month-to-Date

Year-to-Date

March
2020

March
2019

DSR** %
Change

MoM %
Change

March
2020

March
2019

DSR** %
Change

YoY %
Change

American Honda Total

77,153

148,509

-43.9%

-48.0%

298,785

369,787

-19.2%

-19.2%

Total Car Sales

37,175

70,420

-43.0%

-47.2%

131,845

169,083

-22.0%

-22.0%

Total Truck Sales

39,978

78,089

-44.7%

-48.8%

166,940

200,704

-16.8%

-16.8%

Honda

Total Car Sales

34,953

65,829

-42.7%

-46.9%

123,407

158,453

-22.1%

-22.1%

Honda

Total Truck Sales

35,163

68,272

-44.4%

-48.5%

146,846

174,949

-16.1%

-16.1%

Acura

Total Car Sales

2,222

4,591

-47.7%

-51.6%

8,438

10,630

-20.6%

-20.6%

Acura

Total Truck Sales

4,815

9,817

-47.0%

-51.0%

20,094

25,755

-22.0%

-22.0%

* Total Domestic Car Sales

32,996

57,408

-37.9%

-42.5%

115,833

136,122

-14.9%

-14.9%

Honda Division

30,805

52,952

-37.2%

-41.8%

107,574

125,873

-14.5%

-14.5%

Acura Division

2,191

4,456

-46.9%

-50.8%

8,259

10,249

-19.4%

-19.4%

* Total Domestic Truck Sales

39,908

74,131

-41.9%

-46.2%

166,438

191,392

-13.0%

-13.0%

Honda Division

35,093

64,314

-41.1%

-45.4%

146,344

165,637

-11.6%

-11.6%

Acura Division

4,815

9,817

-47.0%

-51.0%

20,094

25,755

-22.0%

-22.0%

  Total Import Car Sales

4,179

13,012

-65.3%

-67.9%

16,012

32,961

-51.4%

-51.4%

Honda Division

4,148

12,877

-65.2%

-67.8%

15,833

32,580

-51.4%

-51.4%

Acura Division

31

135

-75.2%

-77.0%

179

381

-53.0%

-53.0%

  Total Import Truck Sales

70

3,958

-98.1%

-98.2%

502

9,312

-94.6%

-94.6%

Honda Division

70

3,958

-98.1%

-98.2%

502

9,312

-94.6%

-94.6%

Acura Division

0

0

0.0%

0.0%

0

0

0.0%

0.0%

   MODEL BREAKOUT BY DIVISION

Honda Division Total

70,116

134,101

-43.5%

-47.7%

270,253

333,402

-18.9%

-18.9%

ACCORD

13,810

25,371

-41.2%

-45.6%

47,125

64,411

-26.8%

-26.8%

CIVIC

18,273

33,653

-41.4%

-45.7%

63,944

78,185

-18.2%

-18.2%

CLARITY

221

1,416

-83.1%

-84.4%

1,255

3,968

-68.4%

-68.4%

CR-Z

0

0

0.0%

0.0%

1

1

0.0%

0.0%

FIT

1,792

3,238

-40.2%

-44.7%

7,179

6,388

12.4%

12.4%

INSIGHT

857

2,151

-57.0%

-60.2%

3,903

5,500

-29.0%

-29.0%

CR-V

16,891

31,824

-42.7%

-46.9%

71,186

87,280

-18.4%

-18.4%

HR-V

3,843

8,582

-51.6%

-55.2%

19,414

21,649

-10.3%

-10.3%

ODYSSEY

4,274

8,811

-47.6%

-51.5%

16,390

21,297

-23.0%

-23.0%

PASSPORT

1,878

2,840

-28.6%

-33.9%

7,833

4,814

62.7%

62.7%

PILOT

6,445

13,411

-48.1%

-51.9%

23,898

32,957

-27.5%

-27.5%

RIDGELINE

1,832

2,804

-29.4%

-34.7%

8,125

6,952

16.9%

16.9%

Acura Division Total

7,037

14,408

-47.3%

-51.2%

28,532

36,385

-21.6%

-21.6%

ILX

723

1,289

-39.4%

-43.9%

2,741

3,141

-12.7%

-12.7%

NSX

16

26

-33.5%

-38.5%

34

79

-57.0%

-57.0%

RLX / RL

31

135

-75.2%

-77.0%

179

381

-53.0%

-53.0%

TLX

1,452

3,141

-50.1%

-53.8%

5,484

7,029

-22.0%

-22.0%

MDX

2,137

3,982

-42.0%

-46.3%

8,941

10,783

-17.1%

-17.1%

RDX

2,678

5,835

-50.4%

-54.1%

11,153

14,972

-25.5%

-25.5%

Selling Days

25

27

76

76

**** Electrified Vehicles

3,191

5,874

-41.3%

-45.7%

10,579

15,020

-29.6%

-29.6%

*    Honda and Acura vehicles are made of domestic & global sourced parts

**   Daily Selling Rate

**** Electrified Vehicles equal: Total sales of Hybrid (FHEV & PHEV), EVs (BEV) and Fuel Cell Vehicles (FCV) from the Honda and Acura brands.

PDF – https://mma.prnewswire.com/media/1140562/Honda_March_2020_Sales.pdf

Logo – https://mma.prnewswire.com/media/477245/HONDALOGO_Logo.jpg

SOURCE American Honda Motor Co., Inc.

FIBRA Prologis to Host First Quarter 2020 Earnings Conference Call April 23

MEXICO CITY, April 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — FIBRA Prologis (BMV: FIBRAPL 14), a leading owner and operator of Class-A logistics real estate in Mexico, will host a webcast and conference call with senior management to discuss first quarter results, current market conditions and future outlook on Thursday, April 23, at 9:00 a.m. CT/10:00 a.m. ET.

To access a…

MEXICO CITY, April 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — FIBRA Prologis (BMV: FIBRAPL 14), a leading owner and operator of Class-A logistics real estate in Mexico, will host a webcast and conference call with senior management to discuss first quarter results, current market conditions and future outlook on Thursday, April 23, at 9:00 a.m. CT/10:00 a.m. ET.

To access a live broadcast of the call, dial +1 877 256-7020 (toll-free from the United States and Canada), 01 800 926-9157 (toll-free from Mexico) or +1 973 409-9692 from all other countries and enter conference code 7253787. A live webcast can be accessed at www.fibraprologis.com in the Investor Relations section April 23.

A telephonic replay will be available April 23 – April 30 at +1 855 859-2056 from the U.S. and Canada or at +1 404 537-3406 from all other countries using conference code 7253787. The replay will be posted in the Investor Relations section of the FIBRA Prologis website.

ABOUT FIBRA PROLOGIS

FIBRA Prologis is a leading owner and operator of Class-A industrial real estate in Mexico. As of December 31, 2019, FIBRA Prologis was comprised of 191 logistics and manufacturing facilities in six industrial markets in Mexico totaling 34.9 million square feet (3.2 million square meters) of gross leasable area.

FORWARD-LOOKING STATEMENTS

The statements in this release that are not historical facts are forward-looking statements. These forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which FIBRA Prologis operates, management’s beliefs and assumptions made by management.  Such statements involve uncertainties that could significantly impact FIBRA Prologis financial results. Words such as «expects,» «anticipates,» «intends,» «plans,» «believes,» «seeks,» «estimates,» variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature.  All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to rent and occupancy growth, acquisition activity, development activity, disposition activity, general conditions in the geographic areas where we operate, our debt and financial position, are forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. Some of the factors that may affect outcomes and results include, but are not limited to: (i) national, international, regional and local economic climates, (ii) changes in financial markets, interest rates and foreign currency exchange rates, (iii) increased or unanticipated competition for our properties, (iv) risks associated with acquisitions, dispositions and development of properties, (v) maintenance of real estate investment trust («FIBRA») status and tax structuring, (vi) availability of financing and capital, the levels of debt that we maintain and our credit ratings, (vii) risks related to our investments (viii) environmental uncertainties, including risks of natural disasters, and (ix) those additional factors discussed in reports filed with the «Comisión Nacional Bancaria y de Valores» and  the Mexican Stock Exchange by FIBRA Prologis under the heading «Risk Factors.» FIBRA Prologis undertakes no duty to update any forward-looking statements appearing in this release.

Non-Solicitation – Any securities discussed herein or in the accompanying presentations, if any, have not been registered under the Securities Act of 1933 or the securities laws of any state and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act and any applicable state securities laws. Any such announcement does not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein or in the presentations, if and as applicable.

Logo – https://mma.prnewswire.com/media/528012/FIBRA__Logo.jpg

SOURCE FIBRA Prologis

Sendero Health Plans becomes first Austin area affordable care act health plan to waive cost-sharing for COVID-19 treatment

AUSTIN, Texas, April 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — Sendero Health Plans, the community-based non-profit health maintenance organization serving the Austin-area, announced today that the company’s Board of Directors voted to waive all costs to its members for treatment of COVID-19 with in-network providers.

<img id="prnejpg9160left" title="Sendero Health Plans, the…

AUSTIN, Texas, April 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — Sendero Health Plans, the community-based non-profit health maintenance organization serving the Austin-area, announced today that the company’s Board of Directors voted to waive all costs to its members for treatment of COVID-19 with in-network providers.

Sendero Health Plans, the non-profit community health plan based in Austin, Texas, has waived all cost-sharing for the treatment of COVID-19 for its members.

The move makes Sendero the first area affordable care act health plan to waive cost-sharing for treatment and comes as the company also recently waived copayments for in-network doctor visits and lab costs to screen for the disease.

«As a community health plan, Sendero does everything we can to ensure our members get the quality care they need,» said Wesley Durkalski, president and CEO of Sendero Health Plans. «We have eliminated cost sharing for COVID-19 testing and treatment and are working with members with income changes to help them stay covered.  We are helping our members get connected with resources we have, not just for care but for all basic daily needs. We are very happy to offer this to members at a time when there is significant stress over not just household physical and mental health, but household financial health as well.»

In early March, Sendero redeployed staff to conduct outreach calls to over 10 percent of its membership, including all members most at risk of being impacted by this crisis.  This included more than 500 low income, high acuity, former uninsured in Central Health’s Medical Access Program (MAP) members now insured with Sendero. Calls emphasized personal safety, Sendero’s extensive telehealth services and ensuring member access to resources for basic needs. 

Sendero has taken other specific steps in addition to eliminating costs for detection and treatment to assist its members and work with its provider network in response to the COVID-19 crisis including:

  • Providing free prescription delivery through larger pharmacies.
  • Allowing early refills for maintenance medications.
  • Extending provider claims submission deadlines.
  • Working with providers to expand telemedicine and help ensure capacity for care.

«We want our members to focus on the health and well-being of themselves and their families and know that their community health plan is here to help,» said Durkalski. «We are dedicated to keeping our members and their families healthy.»

Health care coverage typically includes member cost sharing which are costs directly paid by member to help lower the monthly costs of premium.  This includes copays, deductibles, and cost sharing.   Copays are fixed amounts that members pay to providers in addition to amounts paid by the insurer.  Deductibles are certain dollar amounts for care that must be paid by the customer first before the insurer can assume payment.  Cost sharing is a split of provider costs between the insurance company and the customer and can represent 70 percent / 30 percent with the insurance company paying the larger portion of health care costs until an annual maximum is reached for the member. 

Sendero’s move eliminates the aforementioned costs for its members for the treatment of COVID-19 and will remain in place until further notice.

Formed in 2011, Sendero Health Plans, Inc. is a community-based nonprofit Health Maintenance Organization supported by the Travis County Health District, known as Central Health, dedicated to improving the health of the community by providing affordable, quality healthcare coverage, especially for Travis County residents with low income. Sendero offers its IdealCare and SelectCare plans on the Federal Health Insurance Marketplace.

CONTACT:

Bill Noble for Sendero Health

512-296-4651 cell 

bnoble@noblestrategic.com

 

Sendero Health Plans Logo

Photo – https://mma.prnewswire.com/media/1140394/Sendero_Health_Plans_COVID_19.jpg  
Logo – https://mma.prnewswire.com/media/377979/Sendero_Health_Plans_Logo.jpg  

SOURCE Sendero Health Plans